How MicroRNAs Command the Battle against Cancer

Hong Helena Wu,Sarah Leng,Consolato Sergi,Roger Leng
DOI: https://doi.org/10.3390/ijms25115865
IF: 5.6
2024-05-29
International Journal of Molecular Sciences
Abstract:MicroRNAs (miRNAs) are small RNA molecules that regulate more than 30% of genes in humans. Recent studies have revealed that miRNAs play a crucial role in tumorigenesis. Large sets of miRNAs in human tumors are under-expressed compared to normal tissues. Furthermore, experiments have shown that interference with miRNA processing enhances tumorigenesis. Multiple studies have documented the causal role of miRNAs in cancer, and miRNA-based anticancer therapies are currently being developed. This review primarily focuses on two key points: (1) miRNAs and their role in human cancer and (2) the regulation of tumor suppressors by miRNAs. The review discusses (a) the regulation of the tumor suppressor p53 by miRNA, (b) the critical role of the miR-144/451 cluster in regulating the Itch-p63-Ago2 pathway, and (c) the regulation of PTEN by miRNAs. Future research and the perspectives of miRNA in cancer are also discussed. Understanding these pathways will open avenues for therapeutic interventions targeting miRNA regulation.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problems that this paper attempts to solve mainly focus on the role of microRNAs (miRNAs) in cancer and their potential as therapeutic targets. Specifically, the paper explores the following aspects: 1. **The role of miRNAs in human cancers**: - The paper discusses how miRNAs affect processes such as cell growth and apoptosis by regulating gene expression, thus playing an important role in tumorigenesis. For example, many miRNAs are down - regulated in human tumors compared with normal tissues, indicating that they may have a tumor - suppressing effect. - The paper also mentions that interfering with the miRNA processing will enhance tumorigenesis, further confirming the importance of miRNAs in cancer. 2. **The regulation of tumor suppressors by miRNAs**: - The paper discusses in detail how miRNAs regulate key tumor suppressors, such as p53, p63 and PTEN. - For example, miR - 34a activates p53 by directly targeting genes such as SIRT1, and miR - 144 increases the p63 protein level by targeting Itch, thus playing a tumor - suppressing role. - For PTEN, miRNAs such as miR - 21 directly target its 3'UTR region, leading to a decrease in PTEN expression and promoting tumor growth and metastasis. 3. **The application of miRNAs in cancer treatment**: - The paper explores the potential of miRNAs as therapeutic agents, including miRNA replacement therapy and miRNA inhibition therapy. - For example, by restoring the expression of tumor - suppressive miRNAs or inhibiting the activity of oncogenic miRNAs, the growth and progression of tumors can be inhibited. - The paper also discusses the challenges and progress of miRNA delivery systems, as well as the prospects of using miRNAs in combination with other treatment methods. 4. **Future research directions**: - The paper points out that although miRNAs show great potential in cancer treatment, some key problems still need to be solved, such as optimizing delivery methods, reducing off - target effects, and ensuring long - term safety and effectiveness. - Future research will further explore the complex interactions between miRNAs and tumor suppressors, providing a theoretical basis for the development of new cancer diagnosis and treatment tools. In conclusion, this paper aims to comprehensively analyze the mechanism of action of miRNAs in cancer and explore the feasibility of using them as potential therapeutic targets, providing new ideas and directions for future cancer research and treatment.